Bactroban and Emphysema - a phase IV clinical study of FDA data

Summary:

Emphysema is reported only by a few people who take Bactroban.

The phase IV clinical study analyzes which people take Bactroban and have Emphysema. It is created by eHealthMe based on reports of 4,457 people who have side effects while taking Bactroban from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 18, 2022

4,457 people reported to have side effects when taking Bactroban.
Among them, 4 people (0.09%) have Emphysema.


What is Bactroban?

Bactroban has active ingredients of mupirocin. It is often used in infection. eHealthMe is studying from 4,210 Bactroban users for its effectiveness, alternative drugs and more.

What is Emphysema?

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs) is found to be associated with 1,674 drugs and 1,051 conditions by eHealthMe.

Number of Bactroban and Emphysema reports submitted per year:

Could Bactroban cause Emphysema?

Gender of people who have Emphysema when taking Bactroban *:

  • female: 75 %
  • male: 25 %

Age of people who have Emphysema when taking Bactroban *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 0.0 %
  • 60+: 66.67 %

Common drugs people take besides Bactroban *:

  1. Zithromax: 3 people, 75.00%
  2. Furosemide: 3 people, 75.00%
  3. Advair Diskus 100/50: 3 people, 75.00%
  4. Levaquin: 3 people, 75.00%
  5. Digoxin: 2 people, 50.00%
  6. Bactrim: 2 people, 50.00%
  7. Singulair: 2 people, 50.00%
  8. Protonix: 2 people, 50.00%
  9. Effexor: 2 people, 50.00%
  10. Prochlorperazine: 2 people, 50.00%

Common side effects people have besides Emphysema *:

  1. Breathing Difficulty: 4 people, 100.00%
  2. Abdominal Distension: 3 people, 75.00%
  3. Cough: 3 people, 75.00%
  4. Injury: 3 people, 75.00%
  5. Pleural Effusion (water on the lungs): 3 people, 75.00%
  6. Pneumonia: 3 people, 75.00%
  7. High Blood Pressure: 3 people, 75.00%
  8. Rashes (redness): 3 people, 75.00%
  9. Nausea (feeling of having an urge to vomit): 3 people, 75.00%
  10. Weakness: 3 people, 75.00%

Common conditions people have *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 25.00%
  2. Constipation: 1 person, 25.00%
  3. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Bactroban and have Emphysema?

Check whether Emphysema is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Emphysema and when was it recovered:

Expand to all the drugs that have ingredients of mupirocin:

Alternative drugs to, pros and cons of Bactroban:

Common Bactroban side effects:

Browse all side effects of Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Emphysema treatments and more:

COVID vaccines that are related to Emphysema:

Common drugs associated with Emphysema:

All the drugs that are associated with Emphysema:

Common conditions associated with Emphysema:

All the conditions that are associated with Emphysema:

How the study uses the data?

The study uses data from the FDA. It is based on mupirocin (the active ingredients of Bactroban) and Bactroban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: